Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment

被引：0
|
作者：
Kibar, A. [1 ]
Ince, B.
Nazari, A.
Toplutas, K. N.
Bilgic, S.
Asa, S.
Besli, R. L. Uslu
Sager, M. S.
Sayman, H. B.
Sonmezoglu, K.
机构：
[1] Istanbul Univ, Fac Med, Cerrahpasa, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-167
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [1] LU-177 DOTATATE THERAPY IN PATIENTS WITH NETS
    Hosking, E.
    McKay, E.
    Browne, E.
    Thomas, D.
    Liauw, W.
    Morris, D.
    Chu, F.
    Hayes, A.
    Butler, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 18 - 18
  • [2] Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Shafaei, S.
    Kropf, S.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S224 - S225
  • [3] Patient release after Lu-177 DOTATATE and Lu-177 PSMA 617 therapies
    Mair, C.
    Warwitz, B.
    Buxbaum, S.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S454 - S454
  • [4] Establishing a Lu-177 Dotatate Therapy Program
    Snyder, W.
    Harpool, K.
    Swanson, J. W.
    Schantz, P.
    Phan, A.
    Dick, J. S.
    Cavanaugh, S. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E499 - E500
  • [5] Lutetium Lu-177 Dotatate Flare Reaction
    Salner, Andrew L.
    Blankenship, Bette
    Dunnack, Hayley
    Niemann, Christopher
    Bertsch, Helaine
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (01)
  • [6] Lu-177 DOTATATE Retreatment: Efficacy and Toxicity
    Santillan, N.
    Ferreira, B.
    Gnanasegaran, G.
    Navalkisoor, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S757 - S757
  • [7] Evaluation of the efficacy of the Lu-177 DOTATATE Treatment in Inoperable/Metastatic Paraganglioma and Malignant Pheochromocytoma
    Guneren, C.
    Besli, L. Uslu
    Sahin, K.
    Sahin, O. E.
    Yildiz, S. Ozel
    Kabasakal, L.
    Sayman, H. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S662 - S662
  • [8] A Case of Meningioma Applied Intraarterial Lu-177 DOTATATE
    Mammadli, K.
    Erkek, B. Karasah
    Parildar, M.
    Sanli, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S660 - S660
  • [9] The clinical efficacy and effectiveness of the Lu-177 DOTATATE therapy
    Acar, E.
    Durak, H.
    Kaya, G. Capa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S723 - S723
  • [10] Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors
    Satapathy, Swayamjeet
    Bhattacharya, Anish
    Sood, Ashwani
    Kapoor, Rakesh
    Gupta, Rajesh
    Sood, Apurva
    Sharma, Prashant
    Khosla, Divya
    Mittal, Bhagwant Rai
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (01) : 23 - 29
12345